Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Ischemic Heart Disease

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 120 articles: HTML format

Single Articles

September 2022
1. HONDA S, Kawasaki T
   Wellens' Syndrome.
   N Engl J Med. 2022;387:e25.
   PubMed    
   
   
   
2. RYDEN L, Standl E
   After Metformin - Next Steps for Type 2 Diabetes with Low Cardiovascular Risk.
   N Engl J Med. 2022;387:1136-1138.
   PubMed    
   
   
   
3. NATHAN DM, Lachin JM, Bebu I, Burch HB, et al
   Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
   N Engl J Med. 2022;387:1075-1088.
   PubMed     Abstract available
   
   
   
4. FUKAMACHI D, Okumura Y
   Giant Coronary-Artery Aneurysm.
   N Engl J Med. 2022;387:e23.
   PubMed    
   
   
   
5. PARK DW, Kang DY, Ahn JM, Yun SC, et al
   Routine Functional Testing or Standard Care in High-Risk Patients after PCI.
   N Engl J Med. 2022;387:905-915.
   PubMed     Abstract available
   
   
   
6. TAMIS-HOLLAND JE
   Surveillance Stress Testing "POST-PCI" - A Future Class III Recommendation?
   N Engl J Med. 2022;387:941-942.
   PubMed    
   
   
   
7. KOO BK, Hu X, Kang J, Zhang J, et al
   Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI.
   N Engl J Med. 2022;387:779-789.
   PubMed     Abstract available
   
   
   August 2022
8. LINDHOLT JS, Sogaard R, Rasmussen LM, Mejldal A, et al
   Five-Year Outcomes of the Danish Cardiovascular Screening (DANCAVAS) Trial.
   N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMoa2208681.
   PubMed     Abstract available
   
   
   
9. CASTELLANO JM, Pocock SJ, Bhatt DL, Quesada AJ, et al
   Polypill Strategy in Secondary Cardiovascular Prevention.
   N Engl J Med. 2022 Aug 26. doi: 10.1056/NEJMoa2208275.
   PubMed     Abstract available
   
   
   
10. LESLIE BR, Gerwin LE
    Gliflozins in the Management of Cardiovascular Disease.
    N Engl J Med. 2022;387:478.
    PubMed    
    
    
    
11. HEYMAN SN, Abassi Z
    Gliflozins in the Management of Cardiovascular Disease.
    N Engl J Med. 2022;387:477-478.
    PubMed    
    
    
    
12. JACOBS DR JR, Sinaiko AR, Woo JG
    Childhood Risk Factors and Adult Cardiovascular Events. Reply.
    N Engl J Med. 2022;387:473-474.
    PubMed    
    
    
    
13. SCHUERMANS A, Lewandowski AJ
    Childhood Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022;387:473.
    PubMed    
    
    
    
14. WANG M, Zhou M, Feng Z
    Childhood Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022;387:472-473.
    PubMed    
    
    
    
15. ORTIZ A
    Childhood Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022;387:472.
    PubMed    
    
    
    July 2022
16. DODD JD, Kofoed KF, Dewey M
    CT or Invasive Coronary Angiography in Stable Chest Pain. Reply.
    N Engl J Med. 2022;387:379-380.
    PubMed    
    
    
    
17. GIBBONS RJ
    CT or Invasive Coronary Angiography in Stable Chest Pain.
    N Engl J Med. 2022;387:378.
    PubMed    
    
    
    
18. DANZI GB, Piccolo R
    CT or Invasive Coronary Angiography in Stable Chest Pain.
    N Engl J Med. 2022;387:378.
    PubMed    
    
    
    
19. BAUMANN AA, Roberts-Thomson RL, Psaltis PJ
    CT or Invasive Coronary Angiography in Stable Chest Pain.
    N Engl J Med. 2022;387:377-378.
    PubMed    
    
    
    
20. REDBERG R, Jeon D
    CT or Invasive Coronary Angiography in Stable Chest Pain.
    N Engl J Med. 2022;387:376-377.
    PubMed    
    
    
    June 2022
21. MA Y, Cook NR, Hu FB
    Daily Urinary Sodium and Potassium Excretion and Cardiovascular Risk. Reply.
    N Engl J Med. 2022;386:e60.
    PubMed    
    
    
    
22. IOANNOU A
    Daily Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
    N Engl J Med. 2022;386:e60.
    PubMed    
    
    
    
23. LIU L, Chen Y, Liu S
    Daily Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
    N Engl J Med. 2022;386:e60.
    PubMed    
    
    
    
24. INOUE K, Nishikawa T
    Daily Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
    N Engl J Med. 2022;386:e60.
    PubMed    
    
    
    May 2022
25. BRAUNWALD E
    Gliflozins in the Management of Cardiovascular Disease.
    N Engl J Med. 2022;386:2024-2034.
    PubMed    
    
    
    
26. FEARON WF, Zimmermann FM, Pijls NHJ
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery. Reply.
    N Engl J Med. 2022;386:1865-1866.
    PubMed    
    
    
    
27. FERLINI M, Munafo A, Visconti LO
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med. 2022;386:1865.
    PubMed    
    
    
    
28. FELDMAN D, Nicolas J, Dangas G
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med. 2022;386:1864-1865.
    PubMed    
    
    
    
29. ROSENBLUM AL, Pack QR
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med. 2022;386:1864.
    PubMed    
    
    
    
30. VAN BELLE E, Patel M, Davies J
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med. 2022;386:1863-1864.
    PubMed    
    
    
    
31. YTTERBERG SR, Bhatt DL, Connell CA
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply.
    N Engl J Med. 2022;386:1768.
    PubMed    
    
    
    
32. D'AMICO F, Peyrin-Biroulet L, Danese S
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:1767-1768.
    PubMed    
    
    
    
33. LADAK K, Crowther M
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:1766-1767.
    PubMed    
    
    
    
34. OZDEDE A, Yazici H
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:1766.
    PubMed    
    
    
    April 2022
35. PITT B, Joseph A, Schloemer P
    Cardiovascular Events with Finerenone in CKD and Diabetes. Reply.
    N Engl J Med. 2022;386:e43.
    PubMed    
    
    
    
36. ORTIZ A, Sarafidis P, Ferro CJ
    Cardiovascular Events with Finerenone in CKD and Diabetes.
    N Engl J Med. 2022;386:e43.
    PubMed    
    
    
    
37. GERARD AO, Laurain A, Esnault VLM
    Cardiovascular Events with Finerenone in CKD and Diabetes.
    N Engl J Med. 2022;386:e43.
    PubMed    
    
    
    
38. KAO PH, Hsu LC
    Cardiovascular Events with Finerenone in CKD and Diabetes.
    N Engl J Med. 2022;386:e43.
    PubMed    
    
    
    
39. INGELFINGER JR
    Childhood Risk Factors and Prediction of Adult Cardiovascular End Points.
    N Engl J Med. 2022 Apr 4. doi: 10.1056/NEJMe2203743.
    PubMed    
    
    
    
40. JACOBS DR JR, Woo JG, Sinaiko AR, Daniels SR, et al
    Childhood Cardiovascular Risk Factors and Adult Cardiovascular Events.
    N Engl J Med. 2022 Apr 4. doi: 10.1056/NEJMoa2109191.
    PubMed     Abstract available
    
    
    March 2022
41. MAUROVICH-HORVAT P, Bosserdt M, Kofoed KF, Rieckmann N, et al
    CT or Invasive Coronary Angiography in Stable Chest Pain.
    N Engl J Med. 2022 Mar 4. doi: 10.1056/NEJMoa2200963.
    PubMed     Abstract available
    
    
    
42. DEVEREAUX PJ, Lamy A, Chan MTV, Allard RV, et al
    High-Sensitivity Troponin I after Cardiac Surgery and 30-Day Mortality.
    N Engl J Med. 2022;386:827-836.
    PubMed     Abstract available
    
    
    February 2022
43. PFEFFER MA, Jering KS, Braunwald E
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction. Reply.
    N Engl J Med. 2022;386:603.
    PubMed    
    
    
    
44. IOANNOU A
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2022;386:603.
    PubMed    
    
    
    January 2022
45. YTTERBERG SR, Bhatt DL, Mikuls TR, Koch GG, et al
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:316-326.
    PubMed     Abstract available
    
    
    
46. FEARON WF, Zimmermann FM, De Bruyne B, Piroth Z, et al
    Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.
    N Engl J Med. 2022;386:128-137.
    PubMed     Abstract available
    
    
    December 2021
47. 
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2021;385:2592.
    PubMed    
    
    
    
48. DESCH S, Freund A, Akin I, Behnes M, et al
    Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation.
    N Engl J Med. 2021;385:2544-2553.
    PubMed     Abstract available
    
    
    
49. NEAL B, Tian M, Wu Y
    Salt Substitute and Cardiovascular Events and Death. Reply.
    N Engl J Med. 2021;385:2493-2494.
    PubMed    
    
    
    
50. BURSZTYN M
    Salt Substitute and Cardiovascular Events and Death.
    N Engl J Med. 2021;385:2493.
    PubMed    
    
    
    
51. MORITA H, Komuro I
    Salt Substitute and Cardiovascular Events and Death.
    N Engl J Med. 2021;385:2492-2493.
    PubMed    
    
    
    
52. ZUCCALA G, Laudisio A, Ciaburri M
    Salt Substitute and Cardiovascular Events and Death.
    N Engl J Med. 2021;385:2492.
    PubMed    
    
    
    
53. GRAUDAL N, Jurgens G, Alderman MH
    Salt Substitute and Cardiovascular Events and Death.
    N Engl J Med. 2021;385:2491-2492.
    PubMed    
    
    
    November 2021
54. MATHEW R, Di Santo P, Hibbert B
    Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. Reply.
    N Engl J Med. 2021;385:2108-2109.
    PubMed    
    
    
    
55. GIBSON LE, Chang MG, Berra L
    Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
    N Engl J Med. 2021;385:2108.
    PubMed    
    
    
    
56. POTTER BJ
    Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
    N Engl J Med. 2021;385:2107-2108.
    PubMed    
    
    
    
57. MA Y, He FJ, Sun Q, Yuan C, et al
    24-Hour Urinary Sodium and Potassium Excretion and Cardiovascular Risk.
    N Engl J Med. 2021 Nov 13. doi: 10.1056/NEJMoa2109794.
    PubMed     Abstract available
    
    
    
58. PFEFFER MA, Claggett B, Lewis EF, Granger CB, et al
    Angiotensin Receptor-Neprilysin Inhibition in Acute Myocardial Infarction.
    N Engl J Med. 2021;385:1845-1855.
    PubMed     Abstract available
    
    
    
59. SINGH AK, Carroll K, McMurray JJV, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113380.
    PubMed     Abstract available
    
    
    
60. SINGH AK, Carroll K, Perkovic V, Solomon S, et al
    Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis.
    N Engl J Med. 2021 Nov 5. doi: 10.1056/NEJMoa2113379.
    PubMed     Abstract available
    
    
    October 2021
61. VALGIMIGLI M, Frigoli E, Heg D, Tijssen J, et al
    Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk.
    N Engl J Med. 2021;385:1643-1655.
    PubMed     Abstract available
    
    
    
62. 
    Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
    N Engl J Med. 2021;385:1632.
    PubMed    
    
    
    August 2021
63. NEAL B, Wu Y, Feng X, Zhang R, et al
    Effect of Salt Substitution on Cardiovascular Events and Death.
    N Engl J Med. 2021 Aug 29. doi: 10.1056/NEJMoa2105675.
    PubMed     Abstract available
    
    
    
64. PITT B, Filippatos G, Agarwal R, Anker SD, et al
    Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
    N Engl J Med. 2021 Aug 28. doi: 10.1056/NEJMoa2110956.
    PubMed     Abstract available
    
    
    
65. JONES WS, Wruck LM, Hernandez AF
    Aspirin Dosing in Cardiovascular Disease. Reply.
    N Engl J Med. 2021;385:765.
    PubMed    
    
    
    
66. JAVOR E, Skelin M, Lucijanic M
    Aspirin Dosing in Cardiovascular Disease.
    N Engl J Med. 2021;385:764-765.
    PubMed    
    
    
    
67. SACRISTAN JA
    Aspirin Dosing in Cardiovascular Disease.
    N Engl J Med. 2021;385:764.
    PubMed    
    
    
    
68. MONACH PA, Branch-Elliman W
    Aspirin Dosing in Cardiovascular Disease.
    N Engl J Med. 2021;385:764.
    PubMed    
    
    
    
69. KALYANI RR
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes. Reply.
    N Engl J Med. 2021;385:671-672.
    PubMed    
    
    
    
70. DONNELLY PE, Winch DE
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
    N Engl J Med. 2021;385:670-671.
    PubMed    
    
    
    
71. BOUSSAGEON R, Maynie-Francois C
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
    N Engl J Med. 2021;385:670.
    PubMed    
    
    
    
72. INZUCCHI SE, Peixoto AJ, Testani JM
    Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
    N Engl J Med. 2021;385:669-670.
    PubMed    
    
    
    
73. KADIRE SR, Udelson J, Budoff MJ
    Imaging in Coronary Artery Disease Risk Stratification.
    N Engl J Med. 2021;385:655-657.
    PubMed    
    
    
    
74. MATHEW R, Di Santo P, Jung RG, Marbach JA, et al
    Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
    N Engl J Med. 2021;385:516-525.
    PubMed     Abstract available
    
    
    July 2021
75. JENKINS DJA, Dehghan M, Yusuf S
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality. Reply.
    N Engl J Med. 2021;385:379-380.
    PubMed    
    
    
    
76. KANTER M, Angadi S, Slavin J
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021;385:378-379.
    PubMed    
    
    
    
77. LEOW MK, Henry CJ
    Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
    N Engl J Med. 2021;385:378.
    PubMed    
    
    
    
78. JUNI P
    PCI for Nonculprit Lesions in Patients with STEMI - No Role for FFR.
    N Engl J Med. 2021;385:370-371.
    PubMed    
    
    
    
79. VARELA DL, Jones TL
    Perivalvular Abscess Causing Coronary-Artery Compression.
    N Engl J Med. 2021;385:e3.
    PubMed    
    
    
    June 2021
80. GERSTEIN HC, Sattar N, Rosenstock J, Ramasundarahettige C, et al
    Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
    N Engl J Med. 2021 Jun 28. doi: 10.1056/NEJMoa2108269.
    PubMed     Abstract available
    
    
    
81. LAU ES, Scirica B, Schaefer IM, Miller AL, et al
    Hypertensive Heartbreak.
    N Engl J Med. 2021;384:2145-2152.
    PubMed    
    
    
    May 2021
82. LOFFI M, Danzi GB
    Isolated Coronary Artery.
    N Engl J Med. 2021;384:e79.
    PubMed    
    
    
    
83. BLANCO-DOMINGUEZ R, Sanchez-Diaz R, de la Fuente H, Jimenez-Borreguero LJ, et al
    A Novel Circulating MicroRNA for the Detection of Acute Myocarditis.
    N Engl J Med. 2021;384:2014-2027.
    PubMed     Abstract available
    
    
    
84. YEKU OO, Medford AJ, Fenves AZ, Uljon SN, et al
    Case 15-2021: A 76-Year-Old Woman with Nausea, Diarrhea, and Acute Kidney Failure.
    N Engl J Med. 2021;384:1943-1950.
    PubMed    
    
    
    
85. PUYMIRAT E, Cayla G, Simon T, Steg PG, et al
    Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.
    N Engl J Med. 2021 May 16. doi: 10.1056/NEJMoa2104650.
    PubMed     Abstract available
    
    
    
86. JONES WS, Mulder H, Wruck LM, Pencina MJ, et al
    Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.
    N Engl J Med. 2021 May 15. doi: 10.1056/NEJMoa2102137.
    PubMed     Abstract available
    
    
    
87. RODRIGUEZ F, Harrington RA
    Antithrombotic Therapy after Acute Coronary Syndromes. Reply.
    N Engl J Med. 2021;384:1873-1874.
    PubMed    
    
    
    
88. PARADA BARCIA J, Raposeiras Roubin S, Abu-Assi E
    Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:1873.
    PubMed    
    
    
    
89. BITTL JA
    Antithrombotic Therapy after Acute Coronary Syndromes.
    N Engl J Med. 2021;384:1872-1873.
    PubMed    
    
    
    
90. KONIG MF, Sathiyakumar V, Phan CM, Schulman SP, et al
    Inside and Out.
    N Engl J Med. 2021;384:1753-1760.
    PubMed    
    
    
    April 2021
91. YUSUF S, Joseph P, Pais P
    Polypill in Persons without Cardiovascular Disease. Reply.
    N Engl J Med. 2021;384:1676-1677.
    PubMed    
    
    
    
92. CAINZOS-ACHIRICA M
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1675-1676.
    PubMed    
    
    
    
93. WALD N, Wald D, Law M
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1675.
    PubMed    
    
    
    
94. MESSERLI FH, Brguljan J, Bangalore S
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1674-1675.
    PubMed    
    
    
    
95. ALAM A, Carey SA, Hall SA
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1674.
    PubMed    
    
    
    
96. GALLIENI M, Paik JM, Fiorina P
    Polypill in Persons without Cardiovascular Disease.
    N Engl J Med. 2021;384:1673-1674.
    PubMed    
    
    
    
97. BHATT DL, Steg PG, Pitt B
    Cardiovascular Outcomes with Sotagliflozin. Reply.
    N Engl J Med. 2021;384:1471-1473.
    PubMed    
    
    
    
98. MARCHAND L, Villar E, Green L
    Cardiovascular Outcomes with Sotagliflozin.
    N Engl J Med. 2021;384:1471.
    PubMed    
    
    
    
99. BAGLIONI P
    Cardiovascular Outcomes with Sotagliflozin.
    N Engl J Med. 2021;384:1470-1471.
    PubMed    
    
    
    
100. KALYANI RR
     Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes.
     N Engl J Med. 2021;384:1248-1260.
     PubMed    
     
     
     March 2021
101. KIM ESH
     Spontaneous Coronary-Artery Dissection. Reply.
     N Engl J Med. 2021;384:1077-1078.
     PubMed    
     
     
     
102. WANG X, Ge J
     Spontaneous Coronary-Artery Dissection.
     N Engl J Med. 2021;384:1077.
     PubMed    
     
     
     
103. CAMPOCHIARO C, Tomelleri A, Dagna L
     Spontaneous Coronary-Artery Dissection.
     N Engl J Med. 2021;384:1077.
     PubMed    
     
     
     
104. GIBBONS GH, Seidman CE, Topol EJ
     Conquering Atherosclerotic Cardiovascular Disease - 50 Years of Progress.
     N Engl J Med. 2021;384:785-788.
     PubMed    
     
     
     February 2021
105. FIOLET ATL, Cornel JH, Thompson PL
     Colchicine in Patients with Chronic Coronary Disease. Reply.
     N Engl J Med. 2021;384:778-779.
     PubMed    
     
     
     
106. D'AMARIO D, Rodolico D, Galli M
     Colchicine in Patients with Chronic Coronary Disease.
     N Engl J Med. 2021;384:778.
     PubMed    
     
     
     
107. LUCIJANIC M, Javor E, Skelin M
     Colchicine in Patients with Chronic Coronary Disease.
     N Engl J Med. 2021;384:777-778.
     PubMed    
     
     
     
108. FISCHER BG
     Colchicine in Patients with Chronic Coronary Disease.
     N Engl J Med. 2021;384:777.
     PubMed    
     
     
     
109. GEBHARD C, Regitz-Zagrosek V
     Colchicine in Patients with Chronic Coronary Disease.
     N Engl J Med. 2021;384:776-777.
     PubMed    
     
     
     
110. KAISER D, Jackson CD
     Colchicine in Patients with Chronic Coronary Disease.
     N Engl J Med. 2021;384:776.
     PubMed    
     
     
     
111. JENKINS DJA, Dehghan M, Mente A, Bangdiwala SI, et al
     Glycemic Index, Glycemic Load, and Cardiovascular Disease and Mortality.
     N Engl J Med. 2021 Feb 24. doi: 10.1056/NEJMoa2007123.
     PubMed     Abstract available
     
     
     
112. RODRIGUEZ F, Harrington RA
     Management of Antithrombotic Therapy after Acute Coronary Syndromes.
     N Engl J Med. 2021;384:452-460.
     PubMed    
     
     
     January 2021
113. HUFFMAN MD, Patel A
     Polypills - A Central Strategy for Improving Cardiovascular Health.
     N Engl J Med. 2021;384:288-289.
     PubMed    
     
     
     
114. SCOTT NS, Thomas SS, DeFaria Yeh D, Fox AS, et al
     Case 2-2021: A 26-Year-Old Pregnant Woman with Ventricular Tachycardia and Shock.
     N Engl J Med. 2021;384:272-282.
     PubMed    
     
     
     December 2020
115. KIM ESH
     Spontaneous Coronary-Artery Dissection.
     N Engl J Med. 2020;383:2358-2370.
     PubMed    
     
     
     November 2020
116. YUSUF S, Joseph P, Dans A, Gao P, et al
     Polypill with or without Aspirin in Persons without Cardiovascular Disease.
     N Engl J Med. 2020 Nov 13. doi: 10.1056/NEJMoa2028220.
     PubMed     Abstract available
     
     
     October 2020
117. LEE TH
     Seizing the Teachable Moment - Lessons from Eisenhower's Heart Attack.
     N Engl J Med. 2020;383:e100.
     PubMed    
     
     
     
118. O'GARA PT, Mack MJ
     Secondary Mitral Regurgitation.
     N Engl J Med. 2020;383:1458-1467.
     PubMed    
     
     
     September 2020
119. CANNON CP, Pratley R, Dagogo-Jack S, Mancuso J, et al
     Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes.
     N Engl J Med. 2020 Sep 23. doi: 10.1056/NEJMoa2004967.
     PubMed     Abstract available
     
     
     August 2020
120. KIRCHHOF P, Camm AJ, Goette A, Brandes A, et al
     Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
     N Engl J Med. 2020 Aug 29. doi: 10.1056/NEJMoa2019422.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: